Fengying Du
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Extracellular vesicles in disease
- Cancer-related gene regulation
- Epigenetics and DNA Methylation
- RNA Research and Splicing
Papers in
-
- Cancer-related molecular mechanisms research 4
- Oncology 7
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Liang Shang (18 shared papers)Leping Li (17 shared papers)Zhen Fang (12 shared papers)Hao Wu (12 shared papers)Jin Liu (9 shared papers)Wei Chong (8 shared papers)Hao Chen (6 shared papers)Zhe Wang (2 shared papers)
- Journals
- Cell Death and Disease (3 papers)Frontiers in Cell and Developmental Biology (2 papers)Theranostics (1 paper)World Journal of Orthopedics (1 paper)Journal of Cancer (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Fengying Du
24 papers receiving 557 citations
Peers
Comparison fields: 5 of 66
- Cancer Research 171
- Molecular Biology 332
- Oncology 98
- Pulmonary and Respiratory Medicine 89
- Immunology 34
Countries citing papers authored by Fengying Du
This map shows the geographic impact of Fengying Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengying Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengying Du more than expected).
Fields of papers citing papers by Fengying Du
This network shows the impact of papers produced by Fengying Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengying Du. The network helps show where Fengying Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Fengying Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 172 | |
| 2 | 2021 | 93 | |
| 3 | 2022 | 85 | |
| 4 | 2023 | 43 | |
| 5 | 2020 | 31 | |
| 6 | 2022 | 17 | |
| 7 | 2020 | 12 | |
| 8 | 2023 | 12 | |
| 9 | 2020 | 11 | |
| 10 | 2021 | 11 | |
| 11 | 2021 | 9 | |
| 12 | Suppression of tumorigenesis in LUAD by LRP1B through regulation of the IL-6-JAK-STAT3 pathway. | 2023 | 8 |
| 13 | 2023 | 8 | |
| 14 | 2022 | 7 | |
| 15 | 2021 | 6 | |
| 16 | 2019 | 5 | |
| 17 | 2022 | 5 | |
| 18 | 2023 | 5 | |
| 19 | 2023 | 5 | |
| 20 | 2020 | 3 |
About Fengying Du
Fengying Du is a scholar working on Cancer Research, Oncology, Gastroenterology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 26 papers that have together received 557 indexed citations. Recurring topics across this work include RNA modifications and cancer (7 papers), Ferroptosis and cancer prognosis (5 papers), Cancer-related molecular mechanisms research (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Epigenetics and DNA Methylation (3 papers), Gastrointestinal Tumor Research and Treatment (3 papers), Cancer-related gene regulation (2 papers) and Genomics and Chromatin Dynamics (2 papers). The work is most often cited by research in Cancer Research (171 citations), Molecular Biology (332 citations), Oncology (98 citations), Pulmonary and Respiratory Medicine (89 citations) and Immunology (34 citations). Fengying Du has collaborated with scholars based in China and United States. Frequent co-authors include Liang Shang, Leping Li, Zhen Fang, Hao Wu, Jin Liu, Wei Chong, Hao Chen, Zhe Wang, Liu Yang and Liming Chen. Their work appears in journals such as Cell Death and Disease, Frontiers in Cell and Developmental Biology, Theranostics, World Journal of Orthopedics and Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.